SUBVENITE
NDC 69102-150, LAMOTRIGINE, tablet, from OWP Pharmaceuticals, Inc..
- Product NDC
- 69102-150
- Status
- Listed
- Labeler
- OWP Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078947
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69102-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE150 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69102-150-06 | 69102015006 | 100 TABLET in 1 BOTTLE (69102-150-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7ad18b68-ba16-4810-9c3e-27fa970454e8NADAC price for package 69102015006
GET /v1/drugs/nadac/69102015006
Use it
Look up 69102-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69102-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69102-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.